30 results match your criteria: "Navarrabiomed-Biomedical Research Center[Affiliation]"
J Proteome Res
March 2018
Immunomodulation Group, Navarrabiomed Biomedical Research Center, Navarra Institute for Health Research (IdiSNA), Irunlarrea 3, 31008 Pamplona, Spain.
Protein S-nitrosylation is a cysteine post-translational modification mediated by nitric oxide. An increasing number of studies highlight S-nitrosylation as an important regulator of signaling involved in numerous cellular processes. Despite the significant progress in the development of redox proteomic methods, identification and quantification of endogeneous S-nitrosylation using high-throughput mass-spectrometry-based methods is a technical challenge because this modification is highly labile.
View Article and Find Full Text PDFArch Immunol Ther Exp (Warsz)
April 2018
Immunomodulation Group, Navarrabiomed Biomedical Research Center, Navarre Institute for Health Research (IdiSNA), Pamplona, Spain.
The current knowledge on tumor-infiltrating myeloid-derived suppressor cells (MDSCs) is based mainly on the extensive work performed in murine models. Data obtained for human counterparts are generated on the basis of tumor analysis from patient samples. Both sources of information led to determination of the main suppressive mechanisms used by these cell subsets in tumor-bearing hosts.
View Article and Find Full Text PDFJ Proteomics
January 2017
ProteoRed-ISCIII, Centro Nacional de Biotecnologia (CSIC), Madrid 28049, Spain. Electronic address:
Unlabelled: Despite the maturity reached by targeted proteomic strategies, reliable and standardized protocols are urgently needed to enhance reproducibility among different laboratories and analytical platforms, facilitating a more widespread use in biomedical research. To achieve this goal, the use of dimensionless relative retention times (iRT), defined on the basis of peptide standard retention times (RT), has lately emerged as a powerful tool. The robustness, reproducibility and utility of this strategy were examined for the first time in a multicentric setting, involving 28 laboratories that included 24 of the Spanish network of proteomics laboratories (ProteoRed-ISCIII).
View Article and Find Full Text PDFJ Proteomics
October 2016
Clinical Neuroproteomics Group, Navarrabiomed Biomedical Research Center, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain; Proteomics Unit, Navarrabiomed Biomedical Research Center, Proteored-ISCIII, Instituto de investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain. Electronic address:
Unlabelled: Olfactory dysfunction is an early event of Alzheimer's disease (AD). However, the mechanisms associated to AD neurodegeneration in olfactory areas are unknown. Here we used double-transgenic amyloid precursor protein/presenilin 1 (APPswe/PS1dE9) mice and label-free quantitative proteomics to analyze early pathological effects on the olfactory bulb (OB) during AD progression.
View Article and Find Full Text PDFVirchows Arch
July 2016
Cancer Epigenetics Group, Navarrabiomed-Biomedical Research Center, Instituto de Investigaciones Sanitarias de Navarra-IdiSNA, Pamplona, Navarra, Spain.
We analysed the promoter methylation status of five genes, involved in adhesion (EPB41L3, TSLC-1), apoptosis (RASSF1, RASSF2) or angiogenesis (TSP-1), in intraoperative sentinel lymph node (SLN) biopsy samples from patients with breast cancer, that had been processed by the one-step nucleic acid amplification (OSNA) technique. SLN resection is performed to estimate the risk of tumour cells in the clinically negative axilla, to avoid unnecessary axillary lymph node dissection. OSNA is currently one of the eligible molecular methods for detecting tumour cells in SLNs.
View Article and Find Full Text PDF